Literature DB >> 8930144

Synergistic behavioral interaction between ethanol and clonidine in rats: role of alpha-2 adrenoceptors.

L Mao1, A A Abdel-Rahman.   

Abstract

Activation of central alpha-2 adrenoceptor leads to a sleep-like state. The present study investigated the effect of ethanol on the loss of the righting reflex (LORR) and hypotension evoked by clonidine in Sprague-Dawley rats. Clonidine at 30 micrograms/kg had no effect on righting reflex, but a higher dose (60 micrograms/kg) elicited variable LORR that averaged 6.5 +/- 4.1 min. Similarly, 0.5 g/kg of ethanol elicited little effect (0.17 +/- 0.17 min), but a higher dose (1 g/kg) produced 2.5 +/- 1.1 min of LORR. Ethanol (0.5 g/kg), combined with the lower dose of clonidine, still had little effect on LORR, but when combined with the higher dose of clonidine the LORR (34.8 +/- 6.5 min) became significantly (P < .01) greater than the sum of the individual effects. Similarly, rats that received a combination of the higher dose (1 g/kg) of ethanol and lower dose (30 micrograms/kg) of clonidine exhibited significantly (P < .01) greater LORR (18.6 +/- 2.5 min) than the sum of individual effects. These findings suggest a synergistic interaction that is dose-related. The alpha-2 adrenoceptor antagonist yohimbine (1 mg/kg), or a mixed antagonist of imidazoline and alpha-2 adrenoceptors, idazoxan (60 micrograms/kg), counteracted the synergistic interaction between ethanol and clonidine on LORR; yohimbine was more effective than idazoxan, but the difference was not significant. Ethanol counteracted the hypotensive effect of clonidine and significantly (P < .05) increased blood pressure to levels higher than preclonidine and corresponding control values. Therefore, the synergistic interaction on LORR cannot be accounted for by an enhanced hypotensive response to clonidine. Furthermore, idazoxan counteracted the hypotensive response to clonidine more effectively than did yohimbine. Taken together, the findings suggest: 1) ethanol differentially influences the sedative (synergistic interaction) and hypotensive (antagonistic interaction) effects of clonidine; 2) the synergistic behavioral interaction is dose-related and involves, at least in part, central alpha-2 adrenoceptors; and 3) the hypotensive effect of clonidine is primarily mediated via imidazoline receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930144

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study.

Authors:  Carolina L Haass-Koffler; Lorenzo Leggio; Dena Davidson; Robert M Swift
Journal:  Alcohol Clin Exp Res       Date:  2015-04       Impact factor: 3.455

Review 2.  Noradrenergic targets for the treatment of alcohol use disorder.

Authors:  Carolina L Haass-Koffler; Robert M Swift; Lorenzo Leggio
Journal:  Psychopharmacology (Berl)       Date:  2018-02-20       Impact factor: 4.530

3.  Differential central NOS-NO signaling underlies clonidine exacerbation of ethanol-evoked behavioral impairment.

Authors:  Tara S Bender; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2009-12-17       Impact factor: 3.455

4.  Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies.

Authors:  Dallece E Curley; Talia R Vasaturo-Kolodner; Nazzareno Cannella; Roberto Ciccocioppo; Carolina L Haass-Koffler
Journal:  Neuropsychopharmacology       Date:  2022-06-27       Impact factor: 8.294

5.  Alpha 2A-adrenergic receptor signaling underlies synergistic enhancement of ethanol-induced behavioral impairment by clonidine.

Authors:  Tara Summer Bender; Abdel A Abdel-Rahman
Journal:  Alcohol Clin Exp Res       Date:  2008-12-13       Impact factor: 3.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.